Cite
Contribution of ribavirin transporter gene polymorphism to treatment response in peginterferon plus ribavirin therapy for HCV genotype 1b patients.
MLA
Tsubota, Akihito, et al. “Contribution of Ribavirin Transporter Gene Polymorphism to Treatment Response in Peginterferon plus Ribavirin Therapy for HCV Genotype 1b Patients.” Liver International, vol. 32, no. 5, May 2012, pp. 826–36. EBSCOhost, https://doi.org/10.1111/j.1478-3231.2011.02727.x.
APA
Tsubota, A., Shimada, N., Yoshizawa, K., Furihata, T., Agata, R., Yumoto, Y., Abe, H., Ika, M., Namiki, Y., Chiba, K., Fujise, K., Tada, N., & Aizawa, Y. (2012). Contribution of ribavirin transporter gene polymorphism to treatment response in peginterferon plus ribavirin therapy for HCV genotype 1b patients. Liver International, 32(5), 826–836. https://doi.org/10.1111/j.1478-3231.2011.02727.x
Chicago
Tsubota, Akihito, Noritomo Shimada, Kai Yoshizawa, Tomomi Furihata, Rie Agata, Yoko Yumoto, Hiroshi Abe, et al. 2012. “Contribution of Ribavirin Transporter Gene Polymorphism to Treatment Response in Peginterferon plus Ribavirin Therapy for HCV Genotype 1b Patients.” Liver International 32 (5): 826–36. doi:10.1111/j.1478-3231.2011.02727.x.